Future of the Pandemic: COVID-19 Variants and Testing
We look forward to you joining us on Tuesday, September 14, 2021 at 12:00 EST for a Lunch & Learn webinar titled: Future of the Pandemic: COVID-19 Variants and Testing.
Presented by Dr. Amanda Naaum, Scientific Liaison Director at Precision Biomonitoring Inc. Dr. Eric Hoskins, former Ontario Minister of Health will co-host the event and answer any questions during the Q&A session.
You can still register and watch the replay!
Here is What You'll Learn
Review how variants emerge, and how to detect and differentiate between the COVID-19 variants
Insights into the Future
Discuss how variants may affect our future, and how it may cause future waves
Reducing the Spread
Review the preventative practices and their effectiveness on reducing the transmission of the virus
Effect of Variants on the Vaccine and Testing
Discuss the effect of COVID-19 variants on vaccines and testing. Highlighting how testing will remain vital as we continue to navigate the pandemic.
Speaker Amanda Naaum
Dr. Amanda Naaum has over ten years of experience in molecular assay development for species identification in both academic and start-up industry settings. Amanda holds a Ph.D. from the University of Guelph. Dr. Naaum was awarded the IUFoST Young Scientist Award (2016), and a Commonwealth Rutherford Fellowship (2018) in recognition of her research and innovation achievements in point of need food species authenticity testing. She now extends this expertise to applications for food and animal safety and environmental monitoring at PBI.
Co-host Eric Hoskins
Eric is a medical doctor with a PhD in Public Health and Epidemiology from Oxford. An Order of Canada recipient, Eric has worked in health systems in Canada and around the world. He was Ontario’s Minister of Health from 2014-2018, and Minister of Economic Development and Trade from 2013-2014. Most recently, Eric was Chair of the Federal Advisory Council on the Implementation of National Pharmacare, and has been
advising the private sector on COVID-19 since the pandemic began. Eric brings his knowledge of health care and innovation to his role as Board director.